• 
• 
• 
• 
• 
• 

Press releases 2006

• 12/11/2006
  Rapid progress in Clinical Phase IIb/III trial for actinic keratosis

• 11/20/2006
  First human study with Biofrontera’s migraine prophylaxis product

• 10/30/2006
  Biofrontera AG announces listing

• 10/24/2006
  Biofrontera führt Privatplatzierung erfolgreich durch und strebt Notierungsaufnahme am geregelten Markt der Börse Düsseldorf an (German only)

• 9/21/2006
  Biofrontera starts Phase IIb/III clinical study for the treatment of actinic keratosis

• 7/6/2006
  Ad-hoc: Biofrontera AG decides to postpone the Initial Public Offering

• 6/28/2006
  Ad-hoc: Biofrontera AG has determined the offer price

• 6/27/2006
  Biofrontera announced positive interim report for the phase II study of BF-derm1

• 1/31/2006
  Biofrontera appoints CFO and General Manager